`

Caribou Biosciences

Biotechnology Research

Specialities :
Next-generation crispr genome editing
Allogeneic car-t cell therapies
Oncology
And autoimmune
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$125.0M
size-icon Size
51 - 200

Frequently Asked Questions About Caribou Biosciences

What does Caribou biosciences do?+

Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases

What are Caribou biosciences's specialties? +

Next-generation crispr genome editing,allogeneic car-t cell therapies,oncology,and autoimmune

What is Caribou biosciences's industry? +

Caribou biosciences operates in the Biotechnology research industry.

What is Caribou biosciences's revenue? +

Caribou biosciences's revenue is 11m - 100m

What is Caribou biosciences's company size? +

Caribou biosciences has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.